Bmoreinc.org Americans struggle with alcoholism each year people worldwide seek treatment for alcoholism each year of individuals with alcoholism relapse to heavy drinking within the first year of seeking treatment deaths are attributed to AUD every year in the US alone dollars lost in annual workplace productivity healthcare and other costs in the US alone Transforming bestinclass research into cuttingedge medicine In partnership with worldleading addiction researchers at the NYU School of Medicine B. More is undertaking clinical research with synthetic psilocybin SYNP101 to establish its safety and efficacy in treating alcoholism and other substance use disorders. Innovators in psychedelic drug development Founded by philanthropists who have pioneered psychedelic research at some of the worlds leading medical schools B. More has built a team that is leveraging decades of expertise in every aspect of pharmaceutical development and commercialization.